12.10.2016 - The newly developed Bristol-Myers (BMS) lung cancer drug Opdivo, a so-called checkpoint inhibitor that stimulates the immune system so that it can attack malignant tumours, has...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)